Tissue necrosis: A burden of pentazocine abuse in South East Nigeria
Journal of West African College of Surgeons · 2024-04 · 14 (2) · 159-165
DOI: 10.4103/jwas.jwas_90_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of West African College of Surgeons, online erschienen am 22.02.2024. Verfasst von Uwakwe Cosmas Mba und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Enugu State University of Science and Technology (ESUT) College of Medicine/ESUT Teaching Hospital, Enugu, Enugu State, Nigeri…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Tissue necrosis from pentazocine abuse is becoming a burden in our environment. Pentazocine is an opioid of the benzomorphan class. It is commonly used for post-traumatic and postoperative pain and vaso-occlusive pain of sickle cell disease (SCD). Its prolonged use can lead to addiction and may result in severe injection site necrosis, often worsened by infection due to a lack of aseptic principles during administration. Although pentazocine is a controlled drug in our environment, it is readily available.
Objectives
To review patients with tissue necrosis from pentazocine injection, share the challenges in their management, and proffer solutions. Materials and Methods: Clinical summaries of patients with tissue necrosis and ulcers due to pentazocine addiction were reviewed.
Results
Twenty-five patients, comprising nine females and 16 males aged 22–61 years, were recorded. Twenty had SCD, while five had other underlying conditions. The duration of abuse was 1–16 years, while the average maximum daily dose was 348.75 ± 346.04 mg. Most patients used multiple sites for injection. Lesions included abscesses, tissue necrosis with ulcers, lymphoedema, exposed necrotic bones, and osteomyelitis. Most had multidisciplinary care. The outcome of wound care was good in two. Three had major limb amputations, four died, three signed against medical advice, six were still receiving care while seven were lost to follow-up. None was completely weaned from the drug at the time of this report.
Conclusion
Rising cases of tissue necrosis from pentazocine abuse are disturbing. Treatment is frustrating. Concerted efforts at prevention should be made to stem the tide.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Enugu State University of Science and Technology (ESUT) College of Medicine/ESUT Teaching Hospital, Enugu, Enugu State, Nigeria.
- Department of Plastic Surgery, National Orthopedic Hospital, Enugu, Enugu State, Nigeria.
- Department of Surgery, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Ebonyi State, Nigeria.
- Department of Psychiatry, ESUT College of Medicine/ESUT Teaching Hospital, Enugu, Nigeria.
- Department of Surgery, University of Nigeria Teaching Hospital, Enugu, Enugu State, Nigeria.
- Department of Anatomic Pathology & Forensic Medicine, ESUT College of Medicine/ESUT Teaching Hospital, Enugu, Enugu State, Nigeria.
Zitieren
APA
Mba, U. C., Onyebueke, G., Okwesili, O. R., Enyanwuma, I. E., Okorie, G. M., Ohayi, S. R., Ugwu, I. C., Ezeme, M. S., & Okenwa, W. O. (2024). Tissue necrosis: A burden of pentazocine abuse in South East Nigeria. Journal of West African College of Surgeons, 14(2), 159-165. https://doi.org/10.4103/jwas.jwas_90_23
Vancouver
Mba UC, Onyebueke G, Okwesili OR, Enyanwuma IE, Okorie GM, Ohayi SR, et al. Tissue necrosis: A burden of pentazocine abuse in South East Nigeria. Journal of West African College of Surgeons. 2024;14(2):159-165. doi:10.4103/jwas.jwas_90_23
BibTeX
@article{Mba2024,
author = {Mba, Uwakwe Cosmas and Onyebueke, Godwin and Okwesili, Obinna Remigius and Enyanwuma, Ifeanyi Edwin and Okorie, Gabriel Maduwuike and Ohayi, Samuel Robsam and Ugwu, Ifeanyi Chinedu and Ezeme, Mark Sunday and Okenwa, Wilfred Okwudili},
title = {Tissue necrosis: A burden of pentazocine abuse in South East Nigeria},
journal = {Journal of West African College of Surgeons},
year = {2024},
volume = {14},
number = {2},
pages = {159--165},
doi = {10.4103/jwas.jwas_90_23}
}
EUVIMED